Short-term changes in posterior vitreous cortex following intravitreal ocriplasmin for symptomatic vitreomacular traction syndrome: a prospective study

[1] Cacciamani A(2017)Longitudinal microperimetry evaluation after intravitreal Ocriplasmin injection for vitreomacular traction Retina 37 1832-1838

[2] Gelso A(2018)Intravitreal Ocriplasmin in clinical practice: predictors of success, visual outcomes, and complications Retina 38 128-136

[3] Simonett JM(2015)Efficacy of intravitreal Ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials Ophthalmology 122 117-122

[4] Ripandelli G(2016)Ocriplasmin use for vitreomacular traction and macular hole: a meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications Graefe’s Arch Clin Exp Ophthal Albrecht von Graefes Arch klinische und Exp Ophthal 254 1247-1256

[5] Pileri M(2016)Baseline predictors of vitreomacular adhesion/traction resolution following an intravitreal injection of Ocriplasmin Ophthalmic Surg Lasers Imaging Retina 47 716-723

[6] Stirpe M(2014)Clinical course of vitreomacular adhesion managed by initial observation Retina 34 442-446

[7] Scarinci F(2015)Clinical course of vitreomacular traction managed initially by observation Ophthalmic Surg Lasers Imaging Retina 46 571-576

[8] Feng HL(2013)The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole Ophthalmology 120 2611-2619

[9] Roth DB(2014)Classification of posterior vitreous detachment Clin Ophthalmol 8 1-10

[10] Hasan A(2017)Tractional abnormalities of the Central Foveal bouquet in epiretinal membranes: clinical spectrum and pathophysiological perspectives Am J Ophthalmol 184 167-180

[1] Cacciamani A(2017)Longitudinal microperimetry evaluation after intravitreal Ocriplasmin injection for vitreomacular traction Retina 37 1832-1838

[2] Gelso A(2018)Intravitreal Ocriplasmin in clinical practice: predictors of success, visual outcomes, and complications Retina 38 128-136

[3] Simonett JM(2015)Efficacy of intravitreal Ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials Ophthalmology 122 117-122

[4] Ripandelli G(2016)Ocriplasmin use for vitreomacular traction and macular hole: a meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications Graefe’s Arch Clin Exp Ophthal Albrecht von Graefes Arch klinische und Exp Ophthal 254 1247-1256

[5] Pileri M(2016)Baseline predictors of vitreomacular adhesion/traction resolution following an intravitreal injection of Ocriplasmin Ophthalmic Surg Lasers Imaging Retina 47 716-723

[6] Stirpe M(2014)Clinical course of vitreomacular adhesion managed by initial observation Retina 34 442-446

[7] Scarinci F(2015)Clinical course of vitreomacular traction managed initially by observation Ophthalmic Surg Lasers Imaging Retina 46 571-576

[8] Feng HL(2013)The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole Ophthalmology 120 2611-2619

[9] Roth DB(2014)Classification of posterior vitreous detachment Clin Ophthalmol 8 1-10

[10] Hasan A(2017)Tractional abnormalities of the Central Foveal bouquet in epiretinal membranes: clinical spectrum and pathophysiological perspectives Am J Ophthalmol 184 167-180